Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1521-1525, July 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ungaro, P. C.
Right arrow Articles by Mardiney, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ungaro, P. C.
Right arrow Articles by Mardiney, M. R., Jr.

Alteration of the Specificity of Antitumor Antisera by the Use of Passively Administered Antibody

Peter C. Ungaro, Walter P. Drake, Donald H. Buchholz and Michael R. Mardiney, Jr.

Section of Immunology and Cell Biology, NIH, National Cancer Institute, Baltimore Cancer Research Center, Baltimore, Maryland 21211

Antispleen antibody was produced in burros by immunization with C57BL/6 spleen lymphocytes. The effect of passive administration of this antiserum in inhibiting antibody production to antigenic determinants common to both C57BL/6 lymphocytes and EL4 tumor cells was studied. Simultaneous immunization with EL4 cells and antispleen antibody resulted in specific alteration of anti-EL4 activity so that cross-reactivity to splenic lymphocytes was diminished. These results demonstrate the potential usefulness of passive antibody administration in altering host immunological responsiveness to antigenic determinants on tumor cells.

Received 2/16/72. Accepted 4/ 3/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.